Table 2.
Comparison of Baseline Users and New Users of Lipid Lowering Medications
| Variable | Baseline Users (n=1059) mean +/− sd or n (%) | New Users (n=487) mean +/− sd or n (%) |
|---|---|---|
| age (years) | 66.0 +/− 8.9 | 66.1 +/− 9.4 |
| male gender | 504 (47.6) | 247 (50.7) |
| Caucasian | 599 (56.6) | 270 (55.4) |
| body mass index | 28.9 +/− 5.2 | 29.1 +/− 5.4 |
| hypertension | 660 (62.3) | 329 (67.6) |
| treated diabetes | 204 (19.3) | 109 (22.4) |
| current smoker | 103 (9.7) | 42 (8.6) |
| treated LDL (mg/dL) | 104.5 +/− 29.2 | 99.5 +/− 31.2 |
| statin use | 969 (91.5) | 438 (89.9) |
| high vs. low daily dose | 356 (33.6) | 167 (34.3) |
| Type of lipid lowering medication: | ||
| Atorvastatin | 484 (45.7) | 226 (46.4) |
| Simvastatin | 286 (27.0) | 115 (23.6) |
| Pravastatin | 126 (11.9) | 51 (10.5) |
| Fluvastatin | 46 (4.3) | 16 (3.3) |
| Lovastatin | 28 (2.6) | 60 (4.6) |
| Fibrates | 57 (5.4) | 51 (4.0) |
| Niacin | 17 (1.6) | 44 (3.4) |
| Resins | 15 (1.4) | 9 (0.7) |
Note: Values are taken from exam 1 for baseline users, exam 2 for new users.